HK Stock MarketDetailed Quotes

00455 TIANDA PHARMA

Watchlist
  • 0.160
  • -0.025-13.51%
Market Closed Dec 27 16:08 CST
344.01MMarket Cap-7.27P/E (TTM)

About TIANDA PHARMA Company

Tianda Pharmaceutical Co., Ltd. is committed to the research and development, production and sale of pharmaceuticals, biotechnology and health care products. Tianda Pharmaceutical is headquartered in Hong Kong, China, and has established marketing centers in Shenzhen and Sydney, and R&D centers and pharmaceutical bases in Zhuhai and Kunming. Both pharmaceutical bases have obtained the new GMP certification issued by China's China Food and Drug Administration, and the Zhuhai pharmaceutical base has also obtained GMP certification issued by the Australian Drug Administration. Tianda Pharmaceutical Co., Ltd. is listed on the main board of the Hong Kong Stock Exchange, stock code: 00455. Tianda Group Co., Ltd. is the controlling shareholder of Tianda Pharmaceutical and holds 55.56% of the shares.

Company Profile

Symbol00455
Company NameTIANDA PHARMA
ISINKYG887471038
Listing DateMar 30, 1992
Issue Price0.88
Shares Offered53.27M share(s)
FoundedJan 21, 1992
Registered AddressCayman Islands
Chairmanwenquan fang
Secretarytaian luo
Audit InstitutionErnst & Young
Company CategoryOther
Registered OfficeCricket Square, Hutchins Drive, P.O. Box 2681, Grand Cayman KY1-1111, Cayman Islands
Head Office and Principal Place of BusinessRoom 2405-2410, 24th Floor, CITIC Tower, 1 Tim Mei Avenue, Central, Hong Kong
Fiscal Year Ends12-31
Employees695
MarketHong Kong motherboard
Phone(852) 2545 3313
Fax(852) 2541 6558
Emailinfo@tianda.com
Business Tianda Pharmaceutical Co., Ltd. is a Hong Kong investment holding company engaged in the pharmaceutical business. The company's main business includes R&D, production and sales of pharmaceuticals, biotechnology and health products. Its products include cardiovascular medicine, pediatric medicine, cold and respiratory medicine, anti-infective drugs, detoxification drugs, and other medicines, as well as the “Wadani” brand series of health products. The company operates in Hong Kong, mainland China, and Australia.

Company Executives

  • Name
  • Position
  • Salary
  • wenquan fang
  • Presidencies, Executive Director, Managing Director, Chairman of the Nomination Committee, Remuneration Committee Members, Member of the Risk Management Committee
  • 60.00K
  • wensheng lv
  • Executive Director
  • 72.00K
  • tao zhong
  • Non-executive Directors, Audit Committee Members
  • 60.00K
  • quanming feng
  • Non-executive Directors
  • --
  • rihui lin
  • Independent Non-Executive Director, Chairman of the Audit Committee, Member of the Risk Management Committee, Nomination Committee Members, Remuneration Committee Members
  • 72.00K
  • chongkang zhao
  • Independent Non-Executive Director, Remuneration Committee Chairman, Chairman of the Risk Management Committee, Audit Committee Members, Nomination Committee Members
  • 72.00K
  • yanfang xian
  • Independent Non-Executive Director, Audit Committee Members, Remuneration Committee Members
  • 37.00K
  • taian luo
  • Company Secretary
  • --
Heat List
HK
Overall
Symbol
Price
% Chg

No Data